S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy
- Resource Type
- article
- Source
- Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
- Subject
Science - Language
- English
- ISSN
- 2041-1723